Main
>
ONCOLOGY (**)
>
Lymphoma>NHL>B-Cell>DLBCL R/R***
>
Treatment
Treatment's subsections
CH. A. CD19. ADC>2 Lines of
DE. M. Fc Modified Cytolytic CD19>
USA. B. CAR T Therapy>
USA. G. CAR T Therapy
USA. G. CD20xCD3 T-cell BiSpecific
USA. G. CD79B Marker Inhibitor+>
USA. K. SINE Compound Tablets
Treatment's products
This section has no products
CH. A. CD19. ADC>2 Lines of
DE. M. Fc Modified Cytolytic CD19>
USA. B. CAR T Therapy>
USA. G. CAR T Therapy
USA. G. CD20xCD3 T-cell BiSpecific
USA. G. CD79B Marker Inhibitor+>
USA. K. SINE Compound Tablets